Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

RNaseq of primary human OA chondrocytes alones or in transwell cocultures with primary human Adipose-derived Mesenchymal Stromal Cells, in presence of 10nM rapamycin or DMSO as vehicle control

ABSTRACT: The objective was to study the combined effects of rapamycin and primary human Adipose-derived Mesenchymal Stromal Cells (AD-MSC) on primary human OA chondrocytes (versus their effects separetely), in an in-vitro model that reproduce an intra-articular injection. For this purpose, P1 OA chondrocytes were seeded in 6-well plates (5x10^5 cells/well) in their proliferative medium for 24h. In parallel, P1 AD-MSC were seeded in 0.4 µm inserts (7.2x10^4) in their proliferative medium for 24h. The next days, all media were removed, cells were washed twice with PBS and media were replaced by miminal chondrogenic medium. Finally, OA chondrocytes were cocultured with AD-MSC (versus alone) in presence of 10nM rapamycin or DMSO (at 1:10000 dilution) as vehicle control for 3 days. At the end, media and inserts were removed and RNA of OA chondrocytes were extracted using RNeasy kit from QIAGEN with an on-column DNase I digestion as manufacturer's instructions. Because of poor quality RNA, one sample (25_DMSO_AD10) and his control (25_RA10_AD10) have been excluded from this analysis. Otherwise, all RNA integrity numbers were above 9 before libraries construction.

INSTRUMENT(S): DNBSEQ-T7

ORGANISM(S): Homo sapiens

SUBMITTER: Damien VERET

PROVIDER: E-MTAB-14216 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Similar Datasets

Project description:Autologous chondrocyte transplantation (ACT) is a routine technique to regenerate focal cartilage lesions. However, patients with osteoarthritis (OA) are lacking an appropriate long-lasting treatment alternative, partly since it is not known if chondrocytes from OA patients have the same chondrogenic differentiation potential as chondrocytes from donors not affected by OA. Articular chondrocytes from patients with OA undergoing total knee replacement (Mankin Score >3, AhlbÃ¤ck Score >2) and from patients undergoing ACT, here referred to as normal donors (ND), were isolated applying protocols used for ACT. Their chondrogenic differentiation potential was evaluated both in high-density pellet and scaffold (Hyaff-11) cultures by histological proteoglycan assessment (Bern Score) and immunohistochemistry for collagen types I and II. Chondrocytes cultured in monolayer and scaffolds were subjected to gene expression profiling using genome-wide oligonucleotide microarrays. Expression data were verified by using quantitative RT-PCR. Chondrocytes from ND and OA donors demonstrated accumulation of comparable amounts of cartilage matrix components, including sulphated proteoglycans and collagen types I and II. The mRNA expression of cartilage markers (COL2A1, COMP, aggrecan, CRTL1, SOX9) and genes involved in matrix synthesis (biglycan, COL9A2, COL11A1, TIMP4, CILP2) was highly induced in 3D cultures of chondrocytes from both donor groups. Genes associated with hypertrophic or OA cartilage (COL10A1, RUNX2, periostin, ALP, PTHR1, MMP13, COL1A1, COL3A1) were not significantly regulated between the two groups of donors. The expression of 661 genes, including COMP, FN1, and SOX9, were differentially regulated between OA and ND chondrocytes cultured in monolayer. During scaffold culture, the differences diminished between the OA and ND chondrocytes, and only 184 genes were differentially regulated. Only few genes were differentially expressed between OA and ND chondrocytes in Hyaff-11 culture. The risk of differentiation into hypertrophic cartilage does not seem to be increased for OA chondrocytes. Our findings suggest that the chondrogenic capacity is not significantly affected by OA and OA chondrocytes fulfill the requirements for matrix-associated ACT. Experiment Overall Design: Gene expression profiles of monolayer cultures (ML; passage 2) and Hyaff-11 scaffold cultures (3D; 14 days in vitro) of chondrocytes from 3 normal donors (ND; underwent ACT treatment) and 3 donors suffering from Osteoarthritis (OA; underwent knee replacement surgery) were determined. Comparative analyses between 3D and ML cultures (3D vs. ML) were performed to assess differentiation capacity of ND and OA chondrocytes. Furthermore, OA-related differences were determined comparing OA and ND monolayers as well as scaffold cultures (each OA vs. ND).

Dataset Information

RNaseq of primary human OA chondrocytes alones or in transwell cocultures with primary human Adipose-derived Mesenchymal Stromal Cells, in presence of 10nM rapamycin or DMSO as vehicle control

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets